Information around the world under one big umbrella or infobigumbrella.

India created a breakthrough in Typhoid Vaccine

  • By Shalini Gupta |
  • Tuesday, January 23rd, 2018 |
  • 0 Comments
 

India created a breakthrough in Typhoid Vaccine. Image Courtesy – Youtube.

Bharat Biotech of Hyderabad, India has created a new typhoid conjugate vaccine that has been clinically tested to apply on children minimum of 6 months old. The company, Bharat Biotech has been pre-qualified by the WHO in December, 2017, has created the medicine in such a way that the medicine will act on children from 6 months old up to 65 years old adult.

The previous Typhoid medicines were applicable to children of minimum 2 years old and above. But, this medicine will give everybody to a long-term protection against Typhoid fever.

Founder and Managing Director of Bharat Biotech, Dr. Krishna Ella, stated that his company has not only done clinical trials in India, but it took a ‘human challenge study’ in Oxford also.

Around 10,000 babies were tested in India along with adults, adolescents, 5-year-old children were carefully tested step by step. In Oxford, the volunteers had to drink high concentration of bacteria during the trial – almost a million of bacteria (parts per million) in a flask of water. Selective groups were given conjugate vaccine, older polysaccharide vaccines and placebo respectively opting for a detailed research report. The Founder and Managing Director of Bharat Biotech, Dr. Krishna Ella needed to prove that their vaccine worked. This research was organised by ‘human challenge’ an organisation founded by Bill and Melinda Gates.

The vaccine by Bharat Biotech proved to be 87% successful in that challenge – published by the world’s oldest and best-known medical journal, ‘The Lancet’, and has been recommended by the Strategic Advisory Group of Experts on Immunization (WHO-SAGE) of World Health Organisation.

The vaccine of Bharat Biotech has drawn the attention of the international vaccine alliance, GAVI. It has reserved $85 million to acquire the vaccine to make it available to GAVI-supported countries.

The vaccine is helping the people to fight against typhoid throughout the world. Though, it has been made by an Indian company, it has been supported by the international medical organisations, and above all, thanks to the medical volunteers who swallowed live bacteria to prove its effectiveness. People around the world will be grateful to them.

 

Shalini Gupta
Shalini Gupta is a teacher at New Delhi with multifarious talents. She has passion for reading, writing, drawing, sketching etc. simultaneously with her teaching job. presently she is writing for Bigumbrella.